Ibrahim, Raihan .

HRN: 08-39-95  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
CEFUROXIME 750MG (VIAL)
10/25/2023
11/01/2023
IV
750mg
TID
Age; Dengue Fever
Checking Final Appropriateness 
10/25/2023
METRONIDAZOLE 500MG (TAB)
10/25/2023
11/01/2023
ORAL
500mg
TID
AGE; Dengue Fever
Checking Final Appropriateness 
10/26/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
10/26/2023
10/28/2023
ORAL
10ml
OD
Ascariasis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: